Advertisement
Document › Details
Bruker Corporation. (6/2/26). "Press Release: Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry". San Diego, CA.
![]() |
Organisation | Bruker Corporation (Nasdaq: BRKR) |
| Group | Bruker (Group) | |
| Organisation 2 | ASMS (American Society for Mass Spectrometry) | |
![]() |
Product | timsMRMS mass spectrometer |
| Product 2 | ASMS 2026 San Diego | |
![]() |
Person | Speir, Paul (Bruker 200905 VP FTMS Bruker Daltonics) |
| Person 2 | Williams, Nora (Bruker 202602 Marketing Director at Bruker Daltonics) | |
At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced energy storage. The timsMRMS is an innovative platform that combines Trapped Ion Mobility Spectrometry (TIMS) with extreme-resolution Magnetic Resonance Mass Spectrometry (MRMS), to unravel the complex molecular makeup of challenging fossil fuels and green energy materials. It accomplishes this with unparalleled mass resolution (>10M) and sub-parts-per-million mass accuracy, plus isotope fine structure identification-confirmation, which enables the most confident identification of molecular species in ultra-complex mixtures.
As the global transition to more renewable energy accelerates, researchers face the challenge of analyzing ultra-high chemical complexity. The timsMRMS offers unprecedented capabilities for two vital areas in energy technology—renewable energy and energy storage.
> Next-Gen Lithium Batteries: The timsMRMS enables ultra-high-confidence molecular characterization of electrolyte formulations, solid-electrolyte interphase (SEI) degradation, and molecular changes during charge-discharge cycles of lithium-ion batteries. This allows materials scientists to better understand and control the chemical mechanisms that dictate battery lifespan, safety, and energy density.
> Advanced Bio-oils & Biofuels: By providing ultra-high-resolution clarity into molecular formulae determination and compound classes, the timsMRMS empowers researchers to address the chemical diversity of pyrolysis and biomass-derived oils, streamlining the development of sustainable, low-carbon transportation fuels.
“Many application areas in energy research present extreme levels of chemical diversity that are incredibly challenging. This has necessitated new analytical capabilities that go beyond traditional LC-MS limits,” said Dr. Paul Speir, Senior Vice President, Global MRMS Business with Bruker. “With the timsMRMS, we are equipping energy researchers with a complete unique tool that provides greater clarity and confidence in characterizing the extreme chemical complexity of next-generation batteries and alternative fuels.”
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Nora Williams
Bruker Daltonics Marketing Communications
T: +49 (421) 2205-2843
E: nora.williams@bruker.com
Investor Relations Contact
Joe Kostka
Director, Investor Relations
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Record changed: 2026-09-02 |
Advertisement
More documents for Bruker (Group)
- [1] Bruker Corporation. (8/11/26). "Press Release: Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories". Boston, MA....
- [2] Bruker Corporation. (8/10/26). "Press Release: Bruker Reports Second Quarter 2026 Financial Results". Billerica, MA....
- [3] Bruker Corporation. (8/10/26). "Press Release: Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development". Leiden....
- [4] Bruker Corporation. (7/15/26). "Press Release: Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER Platform for Pathogenic Microorganisms in Blood". Bremen....
- [5] Bruker Corporation. (6/4/26). "Press Release: Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026". Washington, DC....
- [6] Bruker Corporation. (5/26/26). "Press Release: Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI". Billerica, MA....
- [7] Bruker Corporation. (5/26/26). "Press Release: Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – All to Enable Deep...
- [8] Bruker Corporation. (5/6/26). "Press Release: Bruker Reports First Quarter 2026 Financial Results". Billerica, MA....
- [9] Bruker Corporation. (4/17/26). "Press Release: Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026". Munich....
- [10] Biognosys Group. (4/14/26). "Press Release: Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays". Zürich....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top



![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)



![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)





![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)